Gittler JK, Krueger JG, Guttman-Yassky E. Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis. J Allergy Clin Immunol. 2013;131(2):300–13.

Article  CAS  PubMed  Google Scholar 

Suárez-Fariñas M, Tintle SJ, Shemer A, Chiricozzi A, Nograles K, Cardinale I, et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol. 2011;127(4):954–64.e1-4.

Article  PubMed  PubMed Central  Google Scholar 

Riethmuller C, McAleer MA, Koppes SA, Abdayem R, Franz J, Haftek M, et al. Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis. J Allergy Clin Immunol. 2015;136(6):1573–e802.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brooks SG, Mahmoud RH, Lin RR, Fluhr JW, Yosipovitch G. The Skin Acid Mantle: An Update on Skin pH. J Invest Dermatol. 2025;145(3):509–21.

Article  CAS  PubMed  Google Scholar 

Peng G, Abudouwanli A, Sun Q, Tan Y, Zhao W, Yang M et al. Role of Antimicrobial Peptides in the Pathogenesis of Atopic Dermatitis. The Journal of Dermatology.n/a(n/a).

Uberoi A, Bartow-McKenney C, Zheng Q, Flowers L, Campbell A, Knight SAB, et al. Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor. Cell Host Microbe. 2021;29(8):1235–e488.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hülpüsch C, Rohayem R, Reiger M, Traidl-Hoffmann C. Exploring the skin microbiome in atopic dermatitis pathogenesis and disease modification. J Allergy Clin Immunol. 2024;154(1):31–41.

Article  PubMed  Google Scholar 

Brauweiler AM, Goleva E, Leung DYM. Staphylococcus aureus Lipoteichoic Acid Damages the Skin Barrier through an IL-1-Mediated Pathway. J Invest Dermatol. 2019;139(8):1753–e614.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pytelková J, Orsághová K, Beňová M, Horn M, Schabussova I, Mareš M. Allergenic mites excrete cathepsins B and C as active cysteine proteases distinct from group 1 allergens. Int J Biol Macromol. 2025;331(Pt 2):148383.

Article  PubMed  Google Scholar 

Elias PM. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol. 1983;80(1 Suppl):s44–9.

Article  Google Scholar 

Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Allergy Asthma Rep. 2009;9(4):265–72.

Article  CAS  PubMed  Google Scholar 

Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441–6.

Article  CAS  PubMed  Google Scholar 

Leung DYM, Calatroni A, Zaramela LS, LeBeau PK, Dyjack N, Brar K, et al. The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotype. Sci Transl Med. 2019;11:480.

Article  Google Scholar 

Fukuda K, Ito Y, Furuichi Y, Matsui T, Horikawa H, Miyano T, et al. Three stepwise pH progressions in stratum corneum for homeostatic maintenance of the skin. Nat Commun. 2024;15(1):4062.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Behne MJ, Meyer JW, Hanson KM, Barry NP, Murata S, Crumrine D, et al. NHE1 regulates the stratum corneum permeability barrier homeostasis. Microenvironment acidification assessed with fluorescence lifetime imaging. J Biol Chem. 2002;277(49):47399–406.

Article  CAS  PubMed  Google Scholar 

Fluhr JW, Behne MJ, Brown BE, Moskowitz DG, Selden C, Mao-Qiang M, et al. Stratum corneum acidification in neonatal skin: secretory phospholipase A2 and the sodium/hydrogen antiporter-1 acidify neonatal rat stratum corneum. J Invest Dermatol. 2004;122(2):320–9.

Article  CAS  PubMed  Google Scholar 

Choi EH, Kang H. Importance of Stratum Corneum Acidification to Restore Skin Barrier Function in Eczematous Diseases. Ann Dermatol. 2024;36(1):1–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cork MJ, Danby SG, Vasilopoulos Y, Hadgraft J, Lane ME, Moustafa M, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129(8):1892–908.

Article  CAS  PubMed  Google Scholar 

Kim E, Kim S, Nam GW, Lee H, Moon S, Chang I. The alkaline pH-adapted skin barrier is disrupted severely by SLS-induced irritation. Int J Cosmet Sci. 2009;31(4):263–9.

Article  CAS  PubMed  Google Scholar 

Li R, Rodrigues M, Li L, Winget J, Wang Y, Wang C, et al. Association Between Skin Acid Mantle, Natural Moisturizing Factors, and Antibacterial Activity Against S. aureus in the Stratum Corneum. Clin Cosmet Investig Dermatol. 2023;16:1595–606.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gruber R, Elias PM, Crumrine D, Lin TK, Brandner JM, Hachem JP, et al. Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol. 2011;178(5):2252–63.

Article  PubMed  PubMed Central  Google Scholar 

Bandier J, Johansen JD, Petersen LJ, Carlsen BC. Skin pH, atopic dermatitis, and filaggrin mutations. Dermatitis. 2014;25(3):127–9.

Article  CAS  PubMed  Google Scholar 

Jang H, Matsuda A, Jung K, Karasawa K, Matsuda K, Oida K, et al. Skin pH Is the Master Switch of Kallikrein 5-Mediated Skin Barrier Destruction in a Murine Atopic Dermatitis Model. J Invest Dermatol. 2016;136(1):127–35.

Article  CAS  PubMed  Google Scholar 

Wilson SR, Thé L, Batia LM, Beattie K, Katibah GE, McClain SP, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013;155(2):285–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng Y, Hunt RL, Villaruz AE, Fisher EL, Liu R, Liu Q, et al. Commensal Staphylococcus epidermidis contributes to skin barrier homeostasis by generating protective ceramides. Cell Host Microbe. 2022;30(3):301–e139.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nakatsuji T, Hata TR, Tong Y, Cheng JY, Shafiq F, Butcher AM, et al. Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial. Nat Med. 2021;27(4):700–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith SH, Jayawickreme C, Rickard DJ, Nicodeme E, Bui T, Simmons C, et al. Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans. J Invest Dermatol. 2017;137(10):2110–9.

Article  CAS  PubMed  Google Scholar 

Bissonnette R, Stein Gold L, Kircik L, Simpson EL, Eichenfield LF, Browning J, et al. Skin clearance, duration of treatment-free interval, and safety of tapinarof cream 1% once daily: Results from ADORING 3, a 48-week phase 3 open-label extension trial in adults and children down to 2 years of age with atopic dermatitis. J Am Acad Dermatol. 2025;93(3):707–14.

Article  CAS  PubMed  Google Scholar 

van Hout NE, Nevot G, Jansen PAM, Mannan AA, Zeeuwen P, Hijnen DJ et al. From prebiotics to engineered microbes: microbe-inspired therapies for atopic dermatitis. Br J Dermatol. 2025.

Nilsson EJ, Henning CG, Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol. 1992;27(1):29–34.

Article  CAS  PubMed  Google Scholar 

Stalder JF, Fleury M, Sourisse M, Rostin M, Pheline F, Litoux P. Local steroid therapy and bacterial skin flora in atopic dermatitis. Br J Dermatol. 1994;131(4):536–40.

Article  CAS  PubMed  Google Scholar